A retained catheter for retrobulbar administration of interferon for age-related macular degeneration.
Lincoff
H
H
Department of Ophthalmology, New York Hospital-Cornell Medical Center, New York, USA.
Kreissig
I
I
Gelisken
F
F
Stanga
P
P
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002408:Catheters, Indwelling; D005260:Female; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D005654:Fundus Oculi; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000009:adverse effects; D008268:Macular Degeneration / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009915:Orbit; D011994:Recombinant Proteins; D016896:Treatment Outcome; D014463:Ultrasonography; D014792:Visual Acuity
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins